Sustained low SARS-CoV-2 transmission and widespread population immunity from prior infections plus vaccination underpin the 94.3% market-implied probability of no new coronavirus pandemic in 2026. CDC data through early June show emergency department visits for COVID-19 at just 0.1% with Rt estimates near 0.98 and declining trends in most states, while WHO sentinel surveillance reports stable global positivity around 1.2% and minimal new deaths. Circulating Omicron sublineages, including recently monitored BA.3.2, exhibit immune escape but have not produced elevated incidence or severity meeting variant-of-concern thresholds. Cross-immunity against related sarbecoviruses further reduces emergence risk. Trader consensus reflects these official metrics, yet a novel zoonotic spillover or rapidly evolving variant capable of overcoming existing immunity could still shift trajectories if surveillance gaps widen.